8.490SEK-1.16%Mkt Cap: 8.99M $P/E: —Today
Vivesto AB develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product, Paccal Vet, is a formulation of paclitaxel with its XR-17 encapsulation technology for th…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Pricier
1M Perf
Higher
$67.49BUSDP/E 24.5
$23.23BUSDP/E 20.3
$19.56BUSD
$17.51BUSDP/E 26.8
$15.94BUSDP/E 182.5
$15.23BUSDP/E 31.8
$12.55BUSD
$8.66BUSDP/E 22.0
$8.86BUSD
$7.04BUSDP/E 465.9
$6.69BUSDP/E 24.5
$5.40BUSDP/E 45.7
$3.69BUSDP/E 19.2
$3.53BUSDP/E 11.3
$3.18BUSDP/E 22.2
$2.73BUSDP/E 60.7
$2.74BUSD
$2.51BUSDP/E 17.4
$2.58BUSD
$2.31BUSDP/E 12.5
$1.93BUSDP/E 19.6
$1.86BUSD
$2.00BUSD
$1.93BUSDP/E 21.8
$1.89BUSD
$1.67BUSD
$1.55BUSDP/E 18.3
$1.45BUSDP/E 119.6
$1.38BUSDP/E 14.6
$1.15BUSDP/E 36.3
$1.22BUSDP/E 18.2
$1.10BUSD
$1.22BUSD
$994.14MUSD
$1.04BUSD
$1.06BUSDP/E Infinity
$1.01BUSDP/E 196.8
$931.50MUSDP/E 40.7
$904.70MUSDP/E 14.5
$864.66MUSDP/E 11.8
$811.73MUSDP/E Infinity
$721.01MUSDP/E 7.1
$714.29MUSDP/E 166.5
$536.06MUSD
$515.21MUSDP/E 14.5
$531.98MUSD
$460.32MUSD
$447.39MUSD
$422.06MUSD
$375.76MUSD
$348.74MUSD
$320.48MUSDP/E 43.7
$319.11MUSD
$318.79MUSDP/E 10.2
$338.64MUSD
$295.34MUSDP/E 47.6
$284.75MUSDP/E 51.1
$296.49MUSD
$294.94MUSDP/E 15.2
$267.88MUSDP/E 9.6
$268.97MUSDP/E 13.4
$240.88MUSDP/E 54.0
$213.29MUSD
$198.80MUSD
$189.42MUSD
$187.92MUSDP/E 9.0
$184.50MUSD
$146.24MUSDP/E 18.7
$151.86MUSD
$138.78MUSD
$143.02MUSD
$128.44MUSD
$120.24MUSDP/E 18.7
$97.94MUSD
$84.56MUSDP/E 12.1
$92.30MUSD
$81.82MUSD
$70.91MUSD
$65.95MUSDP/E 55.6
$68.18MUSDP/E 23.4
$63.81MUSD
$65.91MUSD
$57.12MUSD
$61.24MUSD
$57.64MUSD
$50.84MUSD
$48.31MUSD
$42.15MUSD
$34.09MUSDP/E Infinity
$33.97MUSD
$32.00MUSD
$29.51MUSD
$23.51MUSD
$22.80MUSDP/E 197.0
$22.10MUSD
$22.15MUSD
$21.66MUSD
$19.03MUSD
$18.30MUSD
$14.93MUSD
$14.80MUSDP/E 18.0
$14.85MUSD
$13.58MUSD
$12.36MUSD
$10.99MUSD
$10.27MUSD
$9.80MUSD
$7.47MUSDP/E 0.3
$6.48MUSD
$5.98MUSD
$5.83MUSDP/E Infinity
$4.78MUSDP/E 3.8
$3.29MUSDP/E 1.4
$2.06MUSD
$2.01MUSD
$2.05MUSDP/E 35.0
$1.54MUSD
$668.8KUSD
$169.5KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap8.99M $
Enterprise Value5.99M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.26M $
Revenue/Share—
Last Price8.490 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0028925701
Valuation
P/E (Trailing)—
P/E (Forward)-85.00
PEG—
EV/EBITDA-2.00
EV/Revenue—
P/S—
P/B36.64
EPS (TTM)-3.55
EPS (Forward)-0.10
52W Range
7.0007% of range27.76
52W High27.76 SEK
52W Low7.000 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-27.36%
ROA-22.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.25M $
CapEx (TTM)942.27K $
FCF Margin—
FCF Yield-30.58%
Net Debt-3.01M $
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity0.10
Current Ratio3.06
Quick Ratio2.92
Book Value/Sh0.2320 SEK
Cash/Share2.844 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateMay 20, 2026
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)24.00 SEK
Upside (mean)+182.7%
Target Range24.00 SEK – 24.00 SEK
# Analysts1
Ownership
Shares Out.11.07M
Float6.41M
Insiders43.60%
Institutions7.56%
Technical
SMA 509.211 (-7.8%)
SMA 20011.80 (-28.0%)
Beta0.91
S&P 52W Chg20.05%
Avg Vol (30d)97.94K
Avg Vol (10d)21.45K
Technical Indicators
RSI (14)42.3
MACD-0.2705
MACD Signal-0.1923
MACD Hist.-0.0783
BB Upper9.603 SEK
BB Middle8.963 SEK
BB Lower8.322 SEK
BB Width14.29%
ATR (14)0.8447 SEK
Vol Ratio (20d)0.25x